The head of the U.S. Department of Veterans Affairs (VA) is touting his role in promoting psychedelics access for military veterans with serious mental health conditions, saying he “opened that door probably wider than most ever thought” was possible.
During an interview on The Resilient Show podcast that was released last week, VA Secretary Doug Collins described his interest in psychedelic therapy and cross-departmental work to advance clinical trials into substances such as ibogaine and MDMA.
He acknowledged that there are rules in place that make it challenging to provide widespread access without Food and Drug Administration (FDA) approval, but said “there are areas that we can boost clinical trials.”
“I’m the first VA secretary—actually, in a Cabinet meeting about a month and a half ago—to actually bring up psychedelics in a Cabinet meeting,” Collins said. “I think what we got to look at is we’ve got to put alternatives on the map. The VA is going to do our job. We’re going to do within the law and do what we have to do.”
“Look, I’ve never partaken in any of it. Nothing. You know, marijuana—it’s just never been… But what I am seeing, and we see in clinical
Read full article on Marijuana Moment
